Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

U.S. FDA ADVISERS VOTE TO RECOMMEND AUTHORIZATION OF MERCK'S ORAL PILL FOR TREATMENT OF MILD-TO-MODERATE COVID-19 IN ADULTS AT HIGH RISK OF PROGRESSING TO SEVERE DISEASE

11/30/2021 | 04:50pm EST

U.S. FDA ADVISERS VOTE TO RECOMMEND AUTHORIZATION OF MERCK'S ORAL PILL FOR TREATMENT OF MILD-TO-MODERATE COVID-19 IN ADULTS AT HIGH RISK OF PROGRESSING TO SEVERE DISEASE


© Reuters 2021
Latest news "Economy & Forex"
03:15aMARKETMIND : Buy the dip? Or pray for Fed put?
RE
03:14aLme three-month tin falls 3% to $41,300 a tonne…
RE
03:13aIndonesia, Singapore sign extradition, airspace and defence agreements
RE
03:13aChina blue-chip stocks end at 15-mth low ahead of Fed meeting, Lunar New Year
RE
03:12aAt least six killed in Cameroon stadium stampede, says state broadcaster
RE
03:11aSouth African rand weaker on Ukraine tension, Fed worries
RE
03:11aUK's Royal Mail to cut 700 management jobs
RE
03:09aEuro zone bonds supported by stocks slide, geopolitical woes
RE
03:08aUK PM Johnson under fresh pressure over lockdown birthday bash
RE
03:08aFTSE 100 to Gain After Wall Street Closes Higher
DJ
Latest news "Economy & Forex"